In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

Claudio Festuccia, Fulvio Guerra, Sandra D'Ascenzo, Daniela Giunciuglio, Adriana Albini, Mauro Bologna

Research output: Contribution to journalArticle

Abstract

Bombesin is a potent inducer of signal trasduction pathways involved in the proliferation and invasion of androgen-insensitive prostatic tumor cells. This study examines the bombesin-mediated modulation of pericellular proteolysis, monitoring cell capability to migrate and invade basement membranes, using a chemo-invasion assay and analyzing protease production. The results suggest that bombesin could modulate the invasive potential of prostatic cell lines regulating secretion and cell-surface uptake of uPA and MMP-9 activation. In fact, in PC3 and DUI45 cells but not in LNCaP cells, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-I (PAI-I) are induced by bombesin treatment. Bombesin also stimulates cell proliferation and this effect can be inhibited blocking uPA by antibodies and/or uPA inhibitor p-aminobenzamidine. Moreover, HMW-uPA induces cell proliferation in LNCaP cells, which do not produce uPA in the basal conditions, while PC3 and DUI45 cell growth is supported by autotrine production of uPA. The increment of uPA activity on the external plasma membrane causes an increased pericellular plasmin activation. This effect is inhibited by antibodies against uPA and by p-aminobenzamidine. Similarly to EGF, bombesin stimulates secretion and activation of MMP-9 and TIMP-I production. MMP-9 activation can be also obtained by HPIW-uPA treatment, suggesting that plasma-membrane-bound uPA can start a proteolytic cascade involving MMP-9. Therefore, in in vitro assays, bombesin is able to modulate pericellular proteolysis and cell proliferation, differently distributing and activating proteolytic activities. This effect can be related to the 'non- random' degradation of the extracellular matrix in which membrane uPA- uPAreceptor complexes could start bombesin-induced directional protein degradation during metastatic spread.

Original languageEnglish
JournalInternational Journal of Cancer
Volume75
Issue number3
DOIs
Publication statusPublished - Jan 30 1998

Fingerprint

Bombesin
Urokinase-Type Plasminogen Activator
Proteolysis
Neoplasms
Matrix Metalloproteinases
Plasminogen Inactivators
Cell Proliferation
In Vitro Techniques
Cell Membrane
Antibodies
Fibrinolysin
Epidermal Growth Factor
Basement Membrane
Androgens
Extracellular Matrix
Signal Transduction
Peptide Hydrolases

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. / Festuccia, Claudio; Guerra, Fulvio; D'Ascenzo, Sandra; Giunciuglio, Daniela; Albini, Adriana; Bologna, Mauro.

In: International Journal of Cancer, Vol. 75, No. 3, 30.01.1998.

Research output: Contribution to journalArticle

Festuccia, Claudio ; Guerra, Fulvio ; D'Ascenzo, Sandra ; Giunciuglio, Daniela ; Albini, Adriana ; Bologna, Mauro. / In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. In: International Journal of Cancer. 1998 ; Vol. 75, No. 3.
@article{eb5f5862481a4ef5b890beb27def0f4c,
title = "In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin",
abstract = "Bombesin is a potent inducer of signal trasduction pathways involved in the proliferation and invasion of androgen-insensitive prostatic tumor cells. This study examines the bombesin-mediated modulation of pericellular proteolysis, monitoring cell capability to migrate and invade basement membranes, using a chemo-invasion assay and analyzing protease production. The results suggest that bombesin could modulate the invasive potential of prostatic cell lines regulating secretion and cell-surface uptake of uPA and MMP-9 activation. In fact, in PC3 and DUI45 cells but not in LNCaP cells, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-I (PAI-I) are induced by bombesin treatment. Bombesin also stimulates cell proliferation and this effect can be inhibited blocking uPA by antibodies and/or uPA inhibitor p-aminobenzamidine. Moreover, HMW-uPA induces cell proliferation in LNCaP cells, which do not produce uPA in the basal conditions, while PC3 and DUI45 cell growth is supported by autotrine production of uPA. The increment of uPA activity on the external plasma membrane causes an increased pericellular plasmin activation. This effect is inhibited by antibodies against uPA and by p-aminobenzamidine. Similarly to EGF, bombesin stimulates secretion and activation of MMP-9 and TIMP-I production. MMP-9 activation can be also obtained by HPIW-uPA treatment, suggesting that plasma-membrane-bound uPA can start a proteolytic cascade involving MMP-9. Therefore, in in vitro assays, bombesin is able to modulate pericellular proteolysis and cell proliferation, differently distributing and activating proteolytic activities. This effect can be related to the 'non- random' degradation of the extracellular matrix in which membrane uPA- uPAreceptor complexes could start bombesin-induced directional protein degradation during metastatic spread.",
author = "Claudio Festuccia and Fulvio Guerra and Sandra D'Ascenzo and Daniela Giunciuglio and Adriana Albini and Mauro Bologna",
year = "1998",
month = "1",
day = "30",
doi = "10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4",
language = "English",
volume = "75",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

AU - Festuccia, Claudio

AU - Guerra, Fulvio

AU - D'Ascenzo, Sandra

AU - Giunciuglio, Daniela

AU - Albini, Adriana

AU - Bologna, Mauro

PY - 1998/1/30

Y1 - 1998/1/30

N2 - Bombesin is a potent inducer of signal trasduction pathways involved in the proliferation and invasion of androgen-insensitive prostatic tumor cells. This study examines the bombesin-mediated modulation of pericellular proteolysis, monitoring cell capability to migrate and invade basement membranes, using a chemo-invasion assay and analyzing protease production. The results suggest that bombesin could modulate the invasive potential of prostatic cell lines regulating secretion and cell-surface uptake of uPA and MMP-9 activation. In fact, in PC3 and DUI45 cells but not in LNCaP cells, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-I (PAI-I) are induced by bombesin treatment. Bombesin also stimulates cell proliferation and this effect can be inhibited blocking uPA by antibodies and/or uPA inhibitor p-aminobenzamidine. Moreover, HMW-uPA induces cell proliferation in LNCaP cells, which do not produce uPA in the basal conditions, while PC3 and DUI45 cell growth is supported by autotrine production of uPA. The increment of uPA activity on the external plasma membrane causes an increased pericellular plasmin activation. This effect is inhibited by antibodies against uPA and by p-aminobenzamidine. Similarly to EGF, bombesin stimulates secretion and activation of MMP-9 and TIMP-I production. MMP-9 activation can be also obtained by HPIW-uPA treatment, suggesting that plasma-membrane-bound uPA can start a proteolytic cascade involving MMP-9. Therefore, in in vitro assays, bombesin is able to modulate pericellular proteolysis and cell proliferation, differently distributing and activating proteolytic activities. This effect can be related to the 'non- random' degradation of the extracellular matrix in which membrane uPA- uPAreceptor complexes could start bombesin-induced directional protein degradation during metastatic spread.

AB - Bombesin is a potent inducer of signal trasduction pathways involved in the proliferation and invasion of androgen-insensitive prostatic tumor cells. This study examines the bombesin-mediated modulation of pericellular proteolysis, monitoring cell capability to migrate and invade basement membranes, using a chemo-invasion assay and analyzing protease production. The results suggest that bombesin could modulate the invasive potential of prostatic cell lines regulating secretion and cell-surface uptake of uPA and MMP-9 activation. In fact, in PC3 and DUI45 cells but not in LNCaP cells, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-I (PAI-I) are induced by bombesin treatment. Bombesin also stimulates cell proliferation and this effect can be inhibited blocking uPA by antibodies and/or uPA inhibitor p-aminobenzamidine. Moreover, HMW-uPA induces cell proliferation in LNCaP cells, which do not produce uPA in the basal conditions, while PC3 and DUI45 cell growth is supported by autotrine production of uPA. The increment of uPA activity on the external plasma membrane causes an increased pericellular plasmin activation. This effect is inhibited by antibodies against uPA and by p-aminobenzamidine. Similarly to EGF, bombesin stimulates secretion and activation of MMP-9 and TIMP-I production. MMP-9 activation can be also obtained by HPIW-uPA treatment, suggesting that plasma-membrane-bound uPA can start a proteolytic cascade involving MMP-9. Therefore, in in vitro assays, bombesin is able to modulate pericellular proteolysis and cell proliferation, differently distributing and activating proteolytic activities. This effect can be related to the 'non- random' degradation of the extracellular matrix in which membrane uPA- uPAreceptor complexes could start bombesin-induced directional protein degradation during metastatic spread.

UR - http://www.scopus.com/inward/record.url?scp=0032579232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032579232&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4

DO - 10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4

M3 - Article

C2 - 9455804

AN - SCOPUS:0032579232

VL - 75

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -